BushenQiangxin Formula Inhibits Inflammation and Apoptosis in Doxorubicin- Induced Heart Failure via the NF-κB/Bcl-2 Axis.
INTRODUCTION The incidence of chronic heart failure continues to rise annually, making improved prognosis central to reducing its high mortality rate. BushenQiangxin Formula (BSQX) demonstrates significant clinical efficacy, yet its molecular mechanisms for cardiac protection through inhibition of myocardial inflammati...